These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 32156977)

  • 1. [Efficacy of Surgery and Adjuvant Chemotherapy for Distal Cholangiocarcinoma].
    Takahashi K; Kawaida H; Hosomura N; Amemiya H; Kono H; Nakata Y; Shimizu H; Shiraishi K; Furuya S; Akaike H; Kawaguchi Y; Sudo M; Inoue S; Ichikawa D
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2497-2499. PubMed ID: 32156977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orotate phosphoribosyltransferase as a predictor of benefit from S-1 adjuvant chemotherapy for cholangiocarcinoma patients.
    Akahoshi K; Ban D; Kuboki R; Oba A; Ono H; Mitsunori Y; Kudo A; Tanaka S; Tanabe M
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1108-1115. PubMed ID: 30242888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study.
    Wang L; Deng M; Ke Q; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zhou W; Zeng Y
    Cancer Med; 2020 Apr; 9(8):2674-2685. PubMed ID: 32072774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.
    Bergeat D; Turrini O; Courtin-Tanguy L; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
    Langenbecks Arch Surg; 2018 Sep; 403(6):701-709. PubMed ID: 30112638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant S-1 vs gemcitabine for node-positive perihilar cholangiocarcinoma: A propensity score-adjusted analysis.
    Takahashi D; Mizuno T; Yokoyama Y; Igami T; Yamaguchi J; Onoe S; Watanabe N; Maeda O; Ando M; Ebata T
    J Hepatobiliary Pancreat Sci; 2021 Sep; 28(9):716-726. PubMed ID: 34087061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cholangiocellular cancer: the state of the problem and ways to improve the results of surgical treatment].
    Patyutko YI; Polyakov AN; Podluzhnyi DV; Syskova AY; Sagaidak IV; Kotel'nikov AG; Sergeeva ON; Pokataev IA
    Khirurgiia (Mosk); 2018; (12):30-37. PubMed ID: 30560842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma.
    Le Roy B; Gelli M; Pittau G; Allard MA; Pereira B; Serji B; Vibert E; Castaing D; Adam R; Cherqui D; Sa Cunha A
    Br J Surg; 2018 Jun; 105(7):839-847. PubMed ID: 28858392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
    Lunsford KE; Javle M; Heyne K; Shroff RT; Abdel-Wahab R; Gupta N; Mobley CM; Saharia A; Victor DW; Nguyen DT; Graviss EA; Kaseb AO; McFadden RS; Aloia TA; Conrad C; Li XC; Monsour HP; Gaber AO; Vauthey JN; Ghobrial RM;
    Lancet Gastroenterol Hepatol; 2018 May; 3(5):337-348. PubMed ID: 29548617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery.
    Todoroki T
    Hepatogastroenterology; 2000; 47(33):644-9. PubMed ID: 10919004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma.
    Miura JT; Johnston FM; Tsai S; George B; Thomas J; Eastwood D; Banerjee A; Christians KK; Turaga KK; Pawlik TM; Clark Gamblin T
    Ann Surg Oncol; 2015 Oct; 22(11):3716-23. PubMed ID: 25777092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review.
    Wang ML; Ke ZY; Yin S; Liu CH; Huang Q
    Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):110-116. PubMed ID: 30470543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
    Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
    Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
    Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
    Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy combined with immunotherapy in patients with cholangiocarcinoma after radical resection.
    Li XH; Zhou EL; Zhao CY; Cui BK; Dong XY; Du H; Lin XJ
    Cancer Med; 2023 Dec; 12(24):21742-21750. PubMed ID: 38059559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
    Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
    Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
    Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proximal biliary tumors.
    Brown KM; Geller DA
    Surg Clin North Am; 2014 Apr; 94(2):311-23. PubMed ID: 24679423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
    Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
    Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of pharmacokinetic modulation chemotherapy (PMC) using oral UFT and venous 5-FU infusion as adjuvant chemotherapy for intrahepatic cholangiocellular carcinoma].
    Yokoo H; Kamiyama T; Nakagawa T; Nakanishi K; Tahara M; Fukumori D; Kamachi H; Matsushita M; Todo S
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2400-3. PubMed ID: 20037436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: A meta-analysis.
    Ma KW; Cheung TT; Leung B; She BWH; Chok KSH; Chan ACY; Dai WC; Lo CM
    Medicine (Baltimore); 2019 Feb; 98(5):e14013. PubMed ID: 30702559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.